<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Eptifibatide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Eptifibatide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Eptifibatide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Eptifibatide</b> (<b>Integrilin</b>, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.<span class="mw-ref" id="cite_ref-Gribble2010_1-0"><a href="#cite_note-Gribble2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein (<span class=""><a href="javascript:if(confirm('https://www.uniprot.org/uniprot/P22827  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.uniprot.org/uniprot/P22827'" tppabs="https://www.uniprot.org/uniprot/P22827" class="external text external">P22827</a></span>) found in the venom of the southeastern pygmy rattlesnake (<i>Sistrurus miliarius barbouri</i>). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody <a href="Abciximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Abciximab" title="Abciximab">abciximab</a> and the non-peptide <a href="Tirofiban.htm" tppabs="https://ptable.com/wiki/compounds/A/Tirofiban" title="Tirofiban">tirofiban</a> entered the global market.</p>



<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Eptifibatide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Eptifibatide_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eptifibatide_structure.svg.png" data-file-width="512" data-file-height="462" data-file-type="drawing" height="226" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Eptifibatide_ball-and-stick.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eptifibatide_ball-and-stick.png" data-file-width="2000" data-file-height="1240" data-file-type="bitmap" height="155" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Integrilin</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/eptifibatide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/eptifibatide.html'" tppabs="https://www.drugs.com/monograph/eptifibatide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a601210.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a601210.html'" tppabs="https://medlineplus.gov/druginfo/meds/a601210.html" class="external text external">a601210</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Eptifibatide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Eptifibatide'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Eptifibatide" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Eptifibatide&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Eptifibatide&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Eptifibatide&SearchType=BasicSearch" class="external text external">Eptifibatide</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>IV only</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>B01AC16<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=B01AC16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=B01AC16'" tppabs="https://www.whocc.no/atc_ddd_index/?code=B01AC16" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>n/a</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>~25%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>~2.5 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">N<sup>6</sup>-(Aminoiminomethyl)-N<sup>2</sup>-(3-mercapto-1-oxopropyl)-<small>L</small>-lysylglycyl-<small>L</small>-α-aspartyl-<small>L</small>-tryptophyl-<small>L</small>-prolyl-<small>L</small>-cysteinamide, cyclic (1→6)disulfide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=188627-80-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=188627-80-7'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=188627-80-7" class="external text external">188627-80-7</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/123610  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/123610'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/123610" class="external text external">123610</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6585'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6585" class="external text external">6585</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00063  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00063'" tppabs="https://www.drugbank.ca/drugs/DB00063" class="external text external">DB00063</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.10482060.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.10482060.html'" tppabs="http://www.chemspider.com/Chemical-Structure.10482060.html" class="external text external">10482060</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=NA8320J834  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=NA8320J834'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=NA8320J834" class="external text external">NA8320J834</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D06888  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D06888'" tppabs="https://www.kegg.jp/entry/D06888" class="external text external">D06888</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:291902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:291902'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:291902" class="external text external">CHEBI:291902</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1174'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1174" class="external text external">ChEMBL1174</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7046673  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7046673'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7046673" class="external text external">DTXSID7046673</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.169.160  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.169.160'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.169.160" class="external text external">100.169.160</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>35</sub><span>H</span><sub>49</sub><span>N</span><sub>11</sub><span>O</span><sub>9</sub><span>S</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">831.97</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BH%5D%5BC%40%40%5D14CCCN1C%28%3DO%29%5BC%40H%5D%28Cc2c%5BnH%5Dc3ccccc23%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29O%29NC%28%3DO%29CNC%28%3DO%29%5BC%40H%5D%28CCCCNC%28%3DN%29N%29NC%28%3DO%29CCSSC%5BC%40%40H%5D%28C%28N%29%3DO%29NC4%3DO  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BH%5D%5BC%40%40%5D14CCCN1C%28%3DO%29%5BC%40H%5D%28Cc2c%5BnH%5Dc3ccccc23%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29O%29NC%28%3DO%29CNC%28%3DO%29%5BC%40H%5D%28CCCCNC%28%3DN%29N%29NC%28%3DO%29CCSSC%5BC%40%40H%5D%28C%28N%29%3DO%29NC4%3DO'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=%5BH%5D%5BC%40%40%5D14CCCN1C%28%3DO%29%5BC%40H%5D%28Cc2c%5BnH%5Dc3ccccc23%29NC%28%3DO%29%5BC%40H%5D%28CC%28%3DO%29O%29NC%28%3DO%29CNC%28%3DO%29%5BC%40H%5D%28CCCCNC%28%3DN%29N%29NC%28%3DO%29CCSSC%5BC%40%40H%5D%28C%28N%29%3DO%29NC4%3DO" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">[H][C@@]14CCCN1C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@@H](C(N)=O)NC4=O</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:CZKPOZZJODAYPZ-LROMGURASA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461094528&page2=Eptifibatide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461094528&page2=Eptifibatide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461094528&page2=Eptifibatide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Integrilin is sold in two strengths, globally: vials containing 2<span>&nbsp;</span>mg/ml (20<span>&nbsp;</span>mg totally) and 0.75<span>&nbsp;</span>mg/ml (75<span>&nbsp;</span>mg totally). A third size is sold in the US: 100 ml vials containing 2<span>&nbsp;</span>mg/ml (200<span>&nbsp;</span>mg totally).</p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Indications">Indications</h2></summary>
    
<p>Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (i.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).</p>

<p>The drug is usually applied together with <a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">aspirin</a> or <a href="Clopidogrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Clopidogrel" title="Clopidogrel">clopidogrel</a> and (low molecular weight or unfractionated) <a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a>. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide.</p>

<p>The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications_and_precautions">Contraindications and precautions</h2></summary>
    

<ul><li>Thrombocytopenia : The drug is contraindicated in patients with platelet counts of less than 100,000 per μl because no clinical experience exists regarding such patients.</li>
<li>Chronic kidney disease : Eptifibatide undergoes kidney elimination. In such patients with chronic kidney disease where a glycoprotein IIb/IIIa inhibitor is likely to provide benefit, <a href="Abciximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Abciximab" title="Abciximab">Abciximab</a> (trade name: <a href="Abciximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Reopro" title="Reopro" class="mw-redirect">Reopro</a>) is an alternative medication.</li>
<li>Current bleeding tendencies or abnormally prolonged coagulation parameters observed within 30 days before starting therapy with eptifibatide is intended.</li>
<li>Coagulation parameters such as ACT, aPTT, TT, and PT should be followed closely during therapy and afterwards.</li>
<li>Allergy to eptifibatide and/or other ingredients.</li>
<li>Severe, uncontrolled hypertension.</li>
<li>Pregnancy<span>&nbsp;</span>: No experience exists. Pregnant patients should be treated only when clearly needed.</li>
<li>Lactation<span>&nbsp;</span>: No human data exists. Breast-feeding should be avoided during treatment in order to prevent damage to the newborn.</li>
<li>Geriatric patients<span>&nbsp;</span>: No differences in side effects compared with younger patients have been seen. Nevertheless, geriatric patients should be very closely observed for bleeding and other side-effects.</li>
<li>Pediatric patients<span>&nbsp;</span>: Eptifibatide is not indicated in patients below 18 years of age, because no experience exists.</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    

<p>Patients receiving eptifibatide are typically seriously ill and most of them are concomitantly treated with other drugs known to have the potential to cause significant side effects. Therefore, not all side effects listed as follows may be attributable to eptifibatide treatment alone:</p>

<p>The major adverse event in the PURSUIT study was severe bleeding. Bleeding occurred as well at sites of clinical intervention (local sites) as at other sites (systemically) like urogenital bleeds. Sometimes, these events were severe enough to require transfusion of blood or plasma concentrates to stop bleeding and counteract anemia. Severe bleeds occurred in 4.4 and 4.7% of patients respectively depending on the infusion rate (0.5<span>&nbsp;</span>µg/kg/min vs. 0.75<span>&nbsp;</span>µg/kg/min). A few cases of death due to severe bleeding events attributable to drug therapy were reported. No cases of hemorrhagic stroke were seen. Thrombocytopenia of unknown origin (allergic reaction?) was also noticed in 0.2% of patients.</p>

<p>Additionally, hypotension was seen frequently (6%). Cardiovascular failure was also frequent (2%) as were serious arrhythmias (ventricular fibrillation 1.5%, atrial fibrillation 6%). Severe allergic (anaphylactic) reactions occurred in almost 0.2% of patients. These reactions can be life-threatening and may be due to the peptide character of eptifibatide. Other side effects were rare and mild in nature and may not be connected to eptifibatide therapy.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Dosage_regimen">Dosage regimen</h2></summary>
    
<p>The recommended adult dosage is an i.v. loading dose of 180<span>&nbsp;</span>µg/kg over 1 to 2 minutes immediately after diagnosis, followed by continuous i.v.-infusion of 2<span>&nbsp;</span>µg/kg per minute until either hospital discharge or initiation of coronary artery bypass grafting, or for up to 72 hours. At least 4 hours before discharge all local or systemic bleedings should have been controlled and terminated.</p>

<p>Patients weighing &gt;120<span>&nbsp;</span>kg should receive a maximum bolus of 22.6<span>&nbsp;</span>mg followed by a maximum infusion rate of 15<span>&nbsp;</span>mg/h.  Patients with renal impairment evidenced by CrCl &lt;50 ml/min should receive the standard 180<span>&nbsp;</span>µg/kg loading dose followed by infusion at 1<span>&nbsp;</span>µg/kg/min.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Study_results">Study results</h2></summary>
    
<p>Eptifibatide was licensed due to the positive results of the so-called PURSUIT study encompassing 10,948 patients. In this study all patients had suffered either unstable angina or a non-ST-segment-elevation myocardial infarction. Significantly fewer patients developed a myocardial infarction under therapy with eptifibatide. Death rates showed a tendency in favor of eptifibatide, but this superiority was not statistically significant.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Additional_information">Additional information</h2></summary>
    
<p>Sometimes the treating physicians require the patient after discharge from hospital to continue treatment with aspirin or clopidogrel for a few weeks, some months or even for life (as usually is the case with aspirin) to prevent recurrence of symptoms, development of myocardial infarction and/or death related to cardiovascular disease. This advice should be strictly followed.
Eptifibatide is one of very many antiplatelet drugs that all have different consequences on the platelet's activity.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Inventors">Inventors</h2></summary>
    
<p>Eptifibatide was discovered by a team led by Robert M. Scarborough <span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> and David Phillips, at COR Therapeutics which was acquired by Millennium Pharmaceuticals in 2001.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Glycoprotein IIb/IIIa inhibitors</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap"><ol class="mw-references references"><li id="cite_note-Gribble2010-1"> <span id="mw-reference-text-cite_note-Gribble2010-1" class="mw-reference-text"><cite id="CITEREFGordon_W._Gribble2010" class="citation book cs1">Gordon W. Gribble (15 December 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=srxzzUskq4wC&pg=PA11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=srxzzUskq4wC&pg=PA11'" tppabs="https://books.google.com/books?id=srxzzUskq4wC&pg=PA11" class="external text external"><i>Heterocyclic Scaffolds II: Indoles: Synthesis, Properties and Applications</i></a>. Springer. pp.<span>&nbsp;</span>11–. ISBN<span>&nbsp;</span><bdi>978-3-642-15732-5</bdi><span class="reference-accessdate">. Retrieved <span class="nowrap">12 November</span> 2010</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFErin_Allday2006" class="citation news cs1">Erin Allday (August 1, 2006). <a href="javascript:if(confirm('http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2006/08/01/BAGFLK8UD41.DTL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2006/08/01/BAGFLK8UD41.DTL'" tppabs="http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2006/08/01/BAGFLK8UD41.DTL" class="external text external">"Robert Scarborough Jr. -- helped discover important heart drugs"</a>. sfgate.com.</cite></span></li></ol></div></div>

<ul><li>AHFS Database Online</li>
<li>Arzneimittel Datenbank (in German)</li>
<li><a href="javascript:if(confirm('http://www.pharmazeutische-zeitung.de/index.php?id=352&type=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharmazeutische-zeitung.de/index.php?id=352&type=0'" tppabs="http://www.pharmazeutische-zeitung.de/index.php?id=352&type=0" class="external free external">http://www.pharmazeutische-zeitung.de/index.php?id=352&amp;type=0</a> (in German)</li>
<li><a href="javascript:if(confirm('http://www.chemsoc.org/chembytes/ezine/1999/berressem_apr99.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemsoc.org/chembytes/ezine/1999/berressem_apr99.htm'" tppabs="http://www.chemsoc.org/chembytes/ezine/1999/berressem_apr99.htm" class="external free external">http://www.chemsoc.org/chembytes/ezine/1999/berressem_apr99.htm</a> (information on the biological origin of eptifibatide)</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antithrombotics_(thrombolytics,_anticoagulants_and_antiplatelet_drugs)_(B01)" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antithrombotics_(thrombolytics,_anticoagulants_and_antiplatelet_drugs)_(B01)" style="font-size:114%;margin:0 4em">Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antiplatelet drugs</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Glycoprotein IIb/IIIa inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Abciximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Abciximab" title="Abciximab">Abciximab</a></li>
<li><a href="Eptifibatide.htm" tppabs="https://ptable.com/wiki/compounds/A/Eptifibatide" title="Eptifibatide">Eptifibatide</a></li>
<li><span class="new">Orbofiban</span></li>
<li><span class="new">Roxifiban</span></li>
<li>Sibrafiban<sup>§</sup></li>
<li><a href="Tirofiban.htm" tppabs="https://ptable.com/wiki/compounds/A/Tirofiban" title="Tirofiban">Tirofiban</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">ADP receptor/P2Y<sub>12</sub> inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Thienopyridines
<ul><li><a href="Clopidogrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Clopidogrel" title="Clopidogrel">Clopidogrel</a></li>
<li>Prasugrel</li>
<li><a href="Ticlopidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ticlopidine" title="Ticlopidine">Ticlopidine</a></li></ul></li>
<li>Nucleotide/nucleoside analogs
<ul><li>Cangrelor</li>
<li>Elinogrel</li>
<li>Ticagrelor</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Prostaglandin analogue (<a href="Prostacyclin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prostacyclin" title="Prostacyclin">PGI2</a>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Beraprost</li>
<li><a href="Iloprost.htm" tppabs="https://ptable.com/wiki/compounds/A/Iloprost" title="Iloprost">Iloprost</a></li>
<li><a href="Prostacyclin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prostacyclin" title="Prostacyclin">Prostacyclin</a></li>
<li><a href="Treprostinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Treprostinil" title="Treprostinil">Treprostinil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">COX inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Acetylsalicylic acid/Aspirin</a><sup>#</sup></li>
<li>Aloxiprin</li>
<li>Carbasalate calcium</li>
<li>Indobufen</li>
<li>Triflusal</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Thromboxane inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Thromboxane synthase inhibitors
<ul><li><a href="Dipyridamole.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipyridamole" title="Dipyridamole">Dipyridamole</a> (+ aspirin)</li>
<li><a href="Picotamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Picotamide" title="Picotamide">Picotamide</a></li>
<li>Terbogrel</li></ul></li>
<li>Receptor antagonists
<ul><li>Terbogrel</li>
<li>Terutroban<sup>§</sup></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phosphodiesterase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cilostazol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cilostazol" title="Cilostazol">Cilostazol</a></li>
<li><a href="Dipyridamole.htm" tppabs="https://ptable.com/wiki/compounds/A/Dipyridamole" title="Dipyridamole">Dipyridamole</a></li>
<li>Triflusal</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cloricromen</li>
<li>Ditazole</li>
<li>Vorapaxar</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anticoagulants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Vitamin K antagonists<br>(inhibit <a href="Thrombin.htm" tppabs="https://ptable.com/wiki/compounds/A/Thrombin" title="Thrombin">II</a>, VII, IX, X)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Coumarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumarin" title="Coumarin">Coumarins</a>: <a href="Acenocoumarol.htm" tppabs="https://ptable.com/wiki/compounds/A/Acenocoumarol" title="Acenocoumarol">Acenocoumarol</a></li>
<li><a href="Coumatetralyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumatetralyl" title="Coumatetralyl">Coumatetralyl</a></li>
<li><a href="Dicoumarol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicoumarol" title="Dicoumarol">Dicoumarol</a></li>
<li>Ethyl biscoumacetate</li>
<li><a href="Phenprocoumon.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenprocoumon" title="Phenprocoumon">Phenprocoumon</a></li>
<li><a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">Warfarin</a><sup>#</sup></li>
<li><a href="1,3-Indandione.htm" tppabs="https://ptable.com/wiki/compounds/A/1%2C3-Indandione" title="1,3-Indandione">1,3-Indandiones</a>: Clorindione</li>
<li><a href="Diphenadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenadione" title="Diphenadione">Diphenadione</a></li>
<li><a href="Phenindione.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenindione" title="Phenindione">Phenindione</a></li>
<li>Other: Tioclomarol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Factor Xa inhibitors<br>(with some II inhibition)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">Heparin</a> group/<br>glycosaminoglycans/<br>(bind antithrombin)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Low-molecular-weight heparin
<ul><li>Bemiparin</li>
<li>Certoparin</li>
<li><a href="Dalteparin_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Dalteparin_sodium" title="Dalteparin sodium">Dalteparin</a></li>
<li><a href="Enoxaparin_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Enoxaparin_sodium" title="Enoxaparin sodium">Enoxaparin</a></li>
<li>Nadroparin</li>
<li>Parnaparin</li>
<li>Reviparin</li>
<li>Tinzaparin</li></ul></li>
<li>Oligosaccharides
<ul><li><a href="Fondaparinux.htm" tppabs="https://ptable.com/wiki/compounds/A/Fondaparinux" title="Fondaparinux">Fondaparinux</a></li>
<li>Idraparinux<sup>§</sup></li></ul></li>
<li>Heparinoids
<ul><li>Danaparoid</li>
<li><a href="Dermatan_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dermatan_sulfate" title="Dermatan sulfate">Dermatan sulfate</a></li>
<li>Sulodexide</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Direct Xa inhibitors ("xabans")</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Apixaban</li>
<li>Betrixaban</li>
<li>Darexaban<sup>§</sup></li>
<li>Edoxaban</li>
<li>Otamixaban<sup>§</sup></li>
<li>Rivaroxaban</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Direct thrombin (IIa) inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bivalent: Hirudin
<ul><li><a href="Bivalirudin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bivalirudin" title="Bivalirudin">Bivalirudin</a></li>
<li>Desirudin</li>
<li><a href="Lepirudin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lepirudin" title="Lepirudin">Lepirudin</a></li></ul></li>
<li>Univalent: <a href="Argatroban.htm" tppabs="https://ptable.com/wiki/compounds/A/Argatroban" title="Argatroban">Argatroban</a></li>
<li>Dabigatran</li>
<li><span class="new">Efegatran</span></li>
<li>Inogatran<sup>§</sup></li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Melagatran" title="Melagatran" class="mw-redirect">Melagatran</a><sup>‡</sup></li>
<li><a href="Ximelagatran.htm" tppabs="https://ptable.com/wiki/compounds/A/Ximelagatran" title="Ximelagatran">Ximelagatran</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antithrombin III</li>
<li>Defibrotide</li>
<li>Protein C
<ul><li><a href="Drotrecogin_alfa.htm" tppabs="https://ptable.com/wiki/compounds/A/Drotrecogin_alfa" title="Drotrecogin alfa">Drotrecogin alfa</a><sup>‡</sup></li></ul></li>
<li><a href="Ramatroban.htm" tppabs="https://ptable.com/wiki/compounds/A/Ramatroban" title="Ramatroban">Ramatroban</a></li>
<li>REG1</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Thrombolytic drugs/<br>fibrinolytics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Plasminogen activators: r-tPA
<ul><li>Alteplase</li>
<li><a href="Reteplase.htm" tppabs="https://ptable.com/wiki/compounds/A/Reteplase" title="Reteplase">Reteplase</a></li>
<li><a href="Tenecteplase.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenecteplase" title="Tenecteplase">Tenecteplase</a></li>
<li>Desmoteplase<sup>†</sup></li></ul></li>
<li>UPA
<ul><li>Saruplase</li>
<li><a href="Urokinase.htm" tppabs="https://ptable.com/wiki/compounds/A/Urokinase" title="Urokinase">Urokinase</a></li></ul></li>
<li><a href="Anistreplase.htm" tppabs="https://ptable.com/wiki/compounds/A/Anistreplase" title="Anistreplase">Anistreplase</a></li>
<li>Monteplase</li>
<li><a href="Streptokinase.htm" tppabs="https://ptable.com/wiki/compounds/A/Streptokinase" title="Streptokinase">Streptokinase</a><sup>#</sup></li>
<li>Other serine endopeptidases: Ancrod</li>
<li>Brinase</li>
<li>Fibrinolysin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Non-medicinal</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Citrate</li>
<li><a href="Ethylenediaminetetraacetic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylenediaminetetraacetic_acid" title="Ethylenediaminetetraacetic acid">EDTA</a></li>
<li><a href="Oxalate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxalate" title="Oxalate">Oxalate</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>







<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>